The (Minneapolis) Star Tribune
St. Paul-based Ecolab has announced a $3.7 billion plan to acquire Purolite, a provider of purification solutions that will complement Ecolab’s life sciences division.
Purolite is based in King of Prussia, Pa., and employs more than 1,000 people in more than 30 countries. The purchase price is more than nine times Purolite’s annual sales of about $400 million a year.
“Purolite is an acquisition that brings us a fast-growing leader in biopharma and industrial purification solutions with very strong margins. With this transaction, we will significantly increase our opportunities in our high growth, high margin life sciences business, such as the purification of mRNA vaccines and monoclonal antibodies for cancer-treatment drugs,” said…